Loading...
Loading...
BWV| Name | Value |
|---|---|
| Revenues | 1.4M |
| Cost of Revenue | 0.6M |
| Gross Profit | 0.8M |
| Operating Expense | 35.7M |
| Operating I/L | -35.7M |
| Other Income/Expense | -0.5M |
| Interest Income | 0.0M |
| Pretax | -36.2M |
| Income Tax Expense | -1.2M |
| Net Income/Loss | -35.2M |
Blue Water Vaccines, Inc. is a biotechnology company specializing in the research and development of vaccines to prevent infectious diseases globally. The company's lead vaccine programs, BWV-101 and BWV-102, are in preclinical development for influenza and H1 pre-pandemic vaccines, respectively. Additionally, it has a pipeline of other preclinical programs targeting streptococcus pneumoniae induced acute otitis media, norovirus-rotavirus, and norovirus-malaria. Blue Water Vaccines generates revenue through the development and potential commercialization of these vaccines to address critical public health needs.
